Inventor · disambiguated record
Gregg Feinerman
Also filed as: FEINERMAN GREGG
4 granted patents·9 pending applications·17 citations·filing 2005–2017
73Inventor score
Top patents by PatentIndex Score
13 records- 0189US7745400B2Prevention and treatment of ocular side effects with a cyclosporinFEINERMAN GREGG·Filed 2006·Granted Jun 29, 2010·11 cites·11 claims
- 0279US9839667B2Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Granted Dec 12, 2017·2 cites·6 claims
- 0378US8501174B2Prevention and treatment of ocular side effects with a cyclosporinFEINERMAN GREGG·Filed 2010·Granted Aug 6, 2013·4 cites·4 claims
- 0466US2014038904A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 0566US2014030226A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 0666US2014011751A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 0761US10610565B2Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2017·Granted Apr 7, 2020·0 cites·3 claims
- 0859US2014010846A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 0959US2013345147A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 1048US2014011752A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 1148US2014011750A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 1248US2013345148A1Prevention and treatment of ocular side effects with a cyclosporinALLERGAN INC·Filed 2013·Application pending·0 cites
- 1338US2007010879A1Injector system for a lensFEINERMAN GREGG·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →